Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Marinobufagenin Predicts Later Development of Preeclampsia

Jules Puschett of the TAMUS Health Science Center Research Foundation in the U.S. will study initial evidence that elevated levels of the steroid hormone marinobufagenin (MBG) in urine is a very early indicator of preeclampsia in pregnant women. If true, this common and dangerous condition could be diagnosed early with a simple urine dipstick test, and potentially prevented or treated with a molecule called resibufogenin, which counteracts MBG.

More information about Create New Technologies to Improve the Health of Mothers and Newborns (Round 6)